Filtered By:
Condition: Atrial Fibrillation
Procedure: Anesthesia

This page shows you your search results in order of relevance. This is page number 8.

Order by Relevance | Date

Total 276 results found since Jan 2013.

Anaphylaxis-induced atrial fibrillation and anesthesia: Pathophysiologic and therapeutic considerations.
Abstract Atrial fibrillation is the most common cardiac arrhythmia in western society affecting more than 35 million individuals worldwide annually. It is a common postoperative complication and may also occur spontaneously during general and local anesthesia administration. Aging, diabetes mellitus, hypertension, and cardiovascular diseases including cardiomyopathies, congenital cardiac anomalies, heart failure, myocardial ischemia, pericarditis, previous cardiac surgery, vascular disease, and valvular heart disease are some correlated factors. Beyond age, increased incidence of atrial fibrillation has been corre...
Source: Annals of Cardiac Anaesthesia - December 31, 2019 Category: Anesthesiology Authors: Kounis NG, Koniari I, Tzanis G, Soufras GD, Velissaris D, Hahalis G Tags: Ann Card Anaesth Source Type: research

Research Needs and Priorities for Catheter Ablation of Atrial Fibrillation
ATRIAL FIBRILLATION (AF) is the most common chronic arrhythmia encountered by physicians. According to the Framingham Heart Study, the lifetime risk of AF at age 80 is 22.7% in men and 21.7% in women.1 Silent AF occurs in about 30% of patients, and, unfortunately, the first clinical manifestation can be a stroke.2 Thus, early diagnosis and management with anticoagulation are imperative. AF may be paroxysmal, usually lasting for minutes to hours before spontaneously converting back to sinus rhythm.
Source: Journal of Cardiothoracic and Vascular Anesthesia - May 13, 2020 Category: Anesthesiology Authors: Roger L. Royster, Rohesh J. Fernando, Elijah H. Beaty Tags: Editorial Source Type: research

Device-Detected Subclinical Atrial Fibrillation: The Anesthesiologist's Perspective
A RECENT American Heart Association article published in Circulation in December 2019 discussed subclinical atrial fibrillation (SCAF). SCAF, per Noseworthy et al., is defined as asymptomatic atrial fibrillation (AF) episodes captured by various cardiac devices and confirmed by electrocardiogram (ECG) analysis. As more of these devices, including implantable cardiac, wearable, or intracardiac monitors, are implemented, the incidence of SCAF has and will continue to increase. SCAF presents a cardiologist with multiple quandaries, including the initiation of stroke prophylaxis, and if so, how to proceed.
Source: Journal of Cardiothoracic and Vascular Anesthesia - July 16, 2020 Category: Anesthesiology Authors: Samit Ghia, Davendra Mehta, Himani V. Bhatt Tags: Editorial Source Type: research

Left atrial appendage closure with zero fluoroscopic exposure via intracardiac echocardiographic guidance.
CONCLUSION: The fluoroscopy exposure could be minimized, even to zero, in the ICEguided LAAC procedures feasibly and safely using LAmbre devices. The orthogonal triaxial technique is considered efficacious and safe for the procedures. PMID: 32703696 [PubMed - as supplied by publisher]
Source: J Formos Med Assoc - July 19, 2020 Category: General Medicine Authors: Chu H, Du X, Shen C, He B, Feng M, Liu J, Fu G, Wang B Tags: J Formos Med Assoc Source Type: research

Standard procedures in nonoperating room anesthesia
This article provides an overview of standard procedures currently performed in nonoperating room anesthesia (NORA) and highlights anesthetic implications. Recent findings Novel noninvasive interventional procedures remain on the rise, accelerating demand for anesthesia support outside the conventional operating room. The field of interventional oncology has introduced a variety of effective minimally invasive therapies making interventional radiology gain a major role in the management of cancer. Technical innovation brings newer ablative and embolotherapy techniques into practice. Flexible bronchoscopy has replaced ri...
Source: Current Opinion in Anaesthesiology - July 29, 2020 Category: Anesthesiology Tags: NONOPERATING ROOM ANESTHESIA: Edited by Janusz C. Andres Source Type: research

Doing Simple Things Well: Practice Advisory Implementation Reduces Atrial Fibrillation After Cardiac Surgery
Atrial Fibrillation After Cardiac Surgery (AFACS) is associated with increased morbidity, including thromboembolic stroke, renal failure, gastrointestinal complications, infections, and prolonged ventilation, and a significant increase in the risk of subsequent chronic atrial fibrillation.1-4 Furthermore, it is associated with an increase in mortality and hospital and intensive care unit length of stay.1,3 It has a persistently high incidence, ranging from 30% to more than 50%, depending on the type of surgery.
Source: Journal of Cardiothoracic and Vascular Anesthesia - July 29, 2020 Category: Anesthesiology Authors: Martina Buerge, Rosalie Magboo, Dylan Wills, Ioannis Karpouzis, Damian Balmforth, Paul Cooper, Neil Roberts, Ben O'Brien Tags: Special Article Source Type: research

Left Atrial Myxoma Presenting as Cerebral Infarct
ACUTE embolic cerebral stroke is a major health setback for any individual, with increased mortality and morbidity. Embolus arising from cardiac chambers constitutes about 20% of ischemic strokes. Atrial fibrillation is the root cause of more than 50% of cardiogenic emboli, whereas congenital heart diseases, such as atrial septal defect, patent foramen ovale, prosthetic heart valves, rheumatic heart valvular disease, dilated cardiomyopathy, and endocarditis are predisposing factors for cardiogenic emboli.
Source: Journal of Cardiothoracic and Vascular Anesthesia - August 5, 2020 Category: Anesthesiology Authors: Hemant Digambar Waikar, Aylliath Gosalakkal Jayakrishnan, Bodiabaduge Senaka Nimalakeerthi Bandusena, Prakash Priyadarshan, Peter Parthepan Kamalaneson, Abhaya Ileperuma, Praveen Kumar Neema, Richa Dhawan, Mark A. Chaney Tags: Case Conference Source Type: research

Left Atrial Myxoma Presenting as Cerebral Embolism
ACUTE embolic cerebral stroke is a major health setback for any individual, with increased mortality and morbidity. Embolus arising from cardiac chambers constitutes about 20% of ischemic strokes. Atrial fibrillation is the root cause of more than 50% of cardiogenic emboli, whereas congenital heart diseases, such as atrial septal defect, patent foramen ovale, prosthetic heart valves, rheumatic heart valvular disease, dilated cardiomyopathy, and endocarditis are predisposing factors for cardiogenic emboli.
Source: Journal of Cardiothoracic and Vascular Anesthesia - August 5, 2020 Category: Anesthesiology Authors: Hemant Digambar Waikar, Aylliath Gosalakkal Jayakrishnan, Bodiabaduge Senaka Nimalakeerthi Bandusena, Prakash Priyadarshan, Peter Parthepan Kamalaneson, Abhaya Ileperuma, Praveen Kumar Neema, Richa Dhawan, Mark A. Chaney Tags: Case Conference Source Type: research

Antiarrhythmic and cardiac electrophysiological effects of SZV-270, a novel compound with combined Class I/B and Class III effects, in rabbits and dogs.
In conclusion, SZV-270 with its combined Class I/B and III effects can prevent re-entry arrhythmias with reduced risk of provoking drug-induced Torsades de Pointes. PMID: 32970956 [PubMed - as supplied by publisher]
Source: Canadian Journal of Physiology and Pharmacology - September 23, 2020 Category: Drugs & Pharmacology Authors: Varga RS, Hornyik T, Husti Z, Kohajda Z, Krajsovszky G, Nagy N, Jost N, Virág L, Tálosi L, Mátyus P, Varró A, Baczkó I Tags: Can J Physiol Pharmacol Source Type: research

Andexanet Alfa Use in Cardiac Surgical Patients: A Xa Inhibitor and Heparin Reversal Agent
THE NONVITAMIN K direct oral anticoagulants (DOACs) currently are approved for clinical use for the prevention of cerebrovascular embolic stroke in patients with nonvalvular atrial fibrillation, and as antithrombotic therapy and prophylaxis.1 As a result, clinicians should be aware of perioperative management strategies for both elective and emergency surgery in patients receiving these agents. Currently, specific reversal agents, also referred to as antidotes, are available for dabigatran (idarucizumab) and Xa inhibitors (andexanet alfa).
Source: Journal of Cardiothoracic and Vascular Anesthesia - October 13, 2020 Category: Anesthesiology Authors: Jerrold H. Levy, Jean M. Connors Tags: Editorial Source Type: research

How to Manage the Perioperative Patient on Combined Anticoagulant and Antiplatelet Therapy: Comments on the 2020 ACC Consensus Decision Pathway
Antithrombotic drugs are frequently used to prevent or treat various common cardiovascular disorders like acute coronary syndrome (ACS), stroke, atrial fibrillation (AF), and venous thromboembolism (VTE). Mainly, two classes of oral antithrombotic drugs are on market: anticoagulants, which slow down clot formation by reduced thrombin generation and fibrin formation; and antiplatelet drugs, which prevent platelet activation and formation of stable clots. Combined anticoagulant and antiplatelet therapy might be indicated in some patients, but it is associated with increased risk of critical bleeding.
Source: Journal of Cardiothoracic and Vascular Anesthesia - January 28, 2021 Category: Anesthesiology Authors: Daniel Bolliger, Jens Fassl, Gabor Erdoes Tags: Editorial Commentary Source Type: research

General Anesthesia Increased the Risk of Atrial Fibrillation and Acute Kidney Injury in Transcatheter Aortic Valve Replacement
CONCLUSION: GA was associated with higher rates of ICU admission, postoperative AKI, and new-onset AF. The results may provide new evidence that CS challenges universal GA.PMID:33635259 | DOI:10.1532/hsf.3361
Source: The Heart Surgery Forum - February 26, 2021 Category: Cardiovascular & Thoracic Surgery Authors: Ying Liang Wei Wang Xu Wang Mingzheng Liu Feilong Hei Yulong Guan Source Type: research